AMNA
DEAD

Serial Number

79347014

Owner

Luxna Biotech Co., Ltd.

Attorney

M. Scott Alprin

Filing Date

Jan 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AMNA Trademark

Serial Number: 79347014

AMNA is a trademark filed by Luxna Biotech Co., Ltd. on January 14, 2022. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Luxna Biotech Co., Ltd. (7 trademarks)

2-8, Yamadaoka,

Entity Type: 03

Trademark Details

Filing Date

January 14, 2022

Registration Date

Not Registered

Goods & Services

Rental of chemical processing machines and apparatus; providing information relating to material treatment; cryopreservation services; custom manufacturing of nucleic acid materials or synthesis of nucleic acids; custom manufacture of chemical substances; custom manufacture of pharmaceuticals; custom manufacture of synthetic nucleic acids; custom manufacture or preparation of pharmaceuticals; custom extraction, purification, or manufacturing of pharmaceuticals, agricultural preparations, and veterinary preparations; providing information relating to custom preparation and processing of chemicals; custom preparation and processing of chemicals; custom production and processing of proteins and chemicals

Industrial chemicals; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; ceramic glazing in the nature of a dry chemical preparation for use in the manufacture of ceramics; Glaziers' priming putty; oil cement putty; higher fatty acids for industrial purposes; alkaline metals; alkaline-earth metals; non- metallic industrial minerals; chemical compositions for developing and printing photographs; reagent paper not for medical purposes; artificial sweeteners; flour and starch for industrial purposes; Unprocessed plastic in the form of powder or granules; groundwood pulp and chemiground wood pulps for manufacturing purposes; nucleic acid reagents not for medical purposes; chemical reagent for non-medical purposes for diagnosing molecular sequence of biological material such as nucleic acid; chemical reagents for non-medical purposes for use in isolation of ribonucleic acid in physical and chemical experiments; buffer solution and chemical reagent used to introduce molecules such as nucleic acids or their molecular assemblies into cells such as prokaryotic and eukaryotic cells, for non-medical purposes; nucleic acid sequences, other than for medical or veterinary purposes; nucleic acids for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; chemical reagent for analyzing nucleic acid in kit, except for medical or veterinary use; chemical reagent for analyzing nucleic acid, except for medical or veterinary use; reagent for detecting or quantifying nucleic acid, except for medical or veterinary use; Industrial chemical substances for use in discriminant analysis of nucleic acid; nucleolytic enzyme, for industrial purposes; nucleolytic enzyme, for the food industry; reagent for detecting nucleic acid mutation, except for medical or veterinary use; Industrial chemicals for nucleic acid analysis in kit form comprised of detection reagents; Industrial chemicals used as raw materials for conjugation with nucleic acid substances for introducing nucleic acid substances into cells; nucleic acid for use in the manufacture of pharmaceuticals; diagnostic reagents and preparations, except for medical or veterinary use; chemical reagents for use in genetic research for non-medical purposes; reagents for use in genetic research, except for medical or veterinary use; reagents for chemical and research purposes for non-medical purposes

Providing meteorological information; meteorological information; architectural design; architectural services; surveying; geological surveys and research; geological research; designing for others of machines, apparatus, instruments and their parts, and systems composed of such machines, apparatus and instruments; Engineering design services; computer software design, computer programming, or maintenance of computer software; computer programming; technological advice relating to computers, automobiles and industrial machines; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs; research on building construction and city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; product testing and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; installing computer programs on data networks; rental of laboratory apparatus and instruments; rental of technical drawing instruments; Pharmaceutical product development; providing advice, consultancy, and information relating to development of pharmaceuticals; testing, inspection, and research relating to pharmaceuticals, and providing advice, consultancy, and information relating thereto; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; research and development services relating to medicines; testing of pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials for other relating to pharmaceuticals; providing product information about the results of clinical trials for pharmaceuticals; testing of chemicals; development and test of chemical production methods; design of chemical manufacturing plants; advice relating to testing, inspection, or research of chemicals; providing information about testing, inspection, or research of chemicals; testing, inspection, evaluation, or research of chemicals; testing, inspection, or research relating to chemicals; research and development of chemicals; custom pharmaceutical development; custom development of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 1, 2025 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 17, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 31, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 20, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 20, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 20, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 12, 2023 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2023 TROA
ATTORNEY REVIEW COMPLETED
Apr 25, 2023 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Apr 11, 2023 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 5, 2023 CRCV
REFUSAL PROCESSED BY IB
Feb 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 16, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 11, 2022 REPR